COMP <GO>
ACMR vs NVDA // EV/EBITDA & P/E VALUATION
ACM Research Inc. (Class A) (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: ACMR 2
— NVDA 11
▲ EV/EBITDA & P/E VALUATION LEADER: ACMR
LAST: $49.29 (-7.03%) • MKT CAP: $3.43B
valuation
18.2x
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
valuation
23.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACMR VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACMR | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.40% | 74.67% | -30.27 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.80% | 65.06% | -55.26 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.2x | 23.2x | -5.01 | ACMR | /valuation <GO> |
| Free Cash Flow Yield | -1.94% | 2.58% | -4.52 | NVDA | /fcf-yield <GO> |
| Operating Margin | 12.10% | 65.21% | -53.11 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 10.40% | 63.66% | -53.26 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 15.20% | 83.38% | -68.18 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.50 | 19.52 | -16.02 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | ACMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.8 | 51.1 | -16.30 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.7x | 14.5x | +16.23 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.43B | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACMR REV | NVDA REV | ACMR GROSS % | NVDA GROSS % | ACMR FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $901.3M | $130.50B | 44.4% | 75.0% | -$66.6M | $60.85B |
| FY 2024 | $782.1M | $60.92B | 50.1% | 72.7% | $70.0M | $27.02B |
| FY 2023 | $557.7M | $26.97B | — | 56.9% | -$75.3M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACMR // BETA —
NVDA // BETA 2.04